{"mainPropery":{"diseaseId":6964,"diseaseName":"Malignant hyperthermia","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/6964/malignant-hyperthermia","synonyms":["MH","Anesthesia related hyperthermia","Malignant hyperpyrexia","Fulminating hyperpyrexia","Pharmacogenic myopathy","Hyperpyrexia malignant","Hyperthermia of anesthesia","Malignant hyperthermia of anesthesia"],"synonyms-with-source":[{"name":"MH"},{"name":"Anesthesia related hyperthermia"},{"name":"Malignant hyperpyrexia"},{"name":"Fulminating hyperpyrexia"},{"name":"Pharmacogenic myopathy"},{"name":"Hyperpyrexia malignant"},{"name":"Hyperthermia of anesthesia","source":"OrphaData.Org"},{"name":"Malignant hyperthermia of anesthesia","source":"Orphanet"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"423"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":238,"resourceName":"Malignant Hyperthermia Association of the United States (MHAUS)","abbreviation":"","address1":"1 North Main ST","address2":"PO Box 1069","address3":"","address4":"","address5":"","city":"Sherburne","state":"NY","zip":"13460","country":"United States","phone":"+1-607-674-7901 (none emergency)","tty":"","tollFree":"1-800-644-9737 (for emergencies, 24 hour)","fax":"","email":"info@mhaus.org","url":"https://www.mhaus.org/","freeText":"For emergencies outside of North America, call 001-209-417-3722"},{"resourceID":4122,"resourceName":"RYR-1 Foundation","abbreviation":"","address1":"P.O. Box 13312","address2":"","address3":"","address4":"","address5":"","city":"Pittsburgh","state":"PA","zip":"15243","country":"","phone":"412-529-1482","tty":"","tollFree":"","fax":"","email":"lindsay@ryr1.org","url":"https://www.ryr1.org/","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=145600' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Malignant hyperthermia. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Malignant+hyperthermia%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Malignant hyperthermia. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition=malignanthyperthermia' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Malignant hyperthermia. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1080,"resourceId":1761,"resourceName":"European Malignant Hyperthermia Group","descriptionText":"<a href='https://www.emhg.org/recommendations-1' target='_blank'>The European Malignant Hyperthermia Group</a> has established guidelines for molecular genetic testing of malignant susceptibility and for in-vitro contracture testing. To read more, click on the link.","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0024591' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/8/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/001315.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/1445509-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=423' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=mhs' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1702,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='https://www.orpha.net/data/patho/Pro/en/Emergency_MalignantHyperthermia-enPro649.pdf' target='_blank'>Orphanet Emergency Guidelines</a> is an article which is expert-authored and peer-reviewed that is intended to guide health care professionals in emergency situations involving this condition. &nbsp;","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":1705,"resourceId":2846,"resourceName":"Project OrphanAnesthesia","descriptionText":"<a href='https://www.orphananesthesia.eu/en/rare-diseases/published-guidelines/malignant-hyperthermia/123-malignant-hyperthermia/file.html' target='_blank'>Project OrphanAnesthesia</a> is a project whose aim is to create peer-reviewed, readily accessible guidelines for patients with rare diseases and for the anesthesiologists caring for them. The project is a collaborative effort of the German Society of Anesthesiology and Intensive Care, Orphanet, the European Society of Pediatric Anesthesia, anesthetists and rare disease experts with the aim to contribute to patient safety.","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":2021,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='https://omim.org/phenotypicSeries/PS145600' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> lists the subtypes and associated genes for Malignant hyperthermia in a table called Phenotypic Series. Each entry in OMIM includes a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:8545' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Malignant hyperthermia. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Malignant hyperthermia:<br />\r\n<a href='https://www.cmdir.org/' target='_blank'>Congenital Muscle Disease International Registry</a><br /><a href='https://anest.ufl.edu/namhr/' target='_blank'>North American Malignant Hyperthermia Registry of MHAUS</a><br /><a href='https://www.ryr1.org/registry' target='_blank'>The RYR-1 Foundation Registry </a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":4292,"questionText":"What is malignant hyperthermia?","answerText":"<strong>Malignant hyperthermia</strong> (MH) is a severe reaction to certain gases used during anesthesia and/or a muscle relaxant used to temporarily paralyze a person during surgery.&nbsp;Signs and symptoms of MH include marked hyperthermia, a rapid heart rate, rapid breathing, acidosis, muscle rigidity, and breakdown of muscle tissue (rhabdomyolysis). Without prompt treatment, MH can be life-threatening.&nbsp;People who are at increased risk for this reaction are said to have MH susceptibility. Susceptibility to MH may be caused by mutations in any of several genes and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner. People with certain inherited muscle diseases (e.g., <a href=\"http://ghr.nlm.nih.gov/condition/central-core-disease\" target=\"_blank\">central core disease</a> and <a href=\"http://ghr.nlm.nih.gov/condition/multiminicore-disease\" target=\"_blank\">multiminicore disease</a>) also have MH susceptibility.[3229][7496]","dateModified":"2014-06-30T00:00:00"},"basicQuestions":[{"questionId":7587,"questionText":"Is malignant hyperthermia inherited?","answerText":"While malignant hyperthermia itself is not inherited, malignant hyperthermia susceptibility (MHS) is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner. This means that having a mutation in only one copy of the responsible gene is enough to make someone susceptible to having malignant hyperthermia.<br />\r\n<br />\r\nMost people diagnosed with malignant hyperthermia or MHS have a parent with MHS; however, the parent may not have experienced an episode of malignant hyperthermia. Therefore, the family history may appear to be negative when other family members are susceptible. In some cases, a person with MHS is affected due to having a new (de novo) mutation that was not inherited from a parent. Parents of a person with an apparently new mutation may be evaluated by having contracture testing (a muscle biopsy to determine susceptibility) or molecular genetic testing, if the mutation in the affected person is known.<br />\r\n<br />\r\nEach child of a person with MHS has a 50% (1 in 2) risk to inherit MHS.<br />\r\n<br />\r\nThe risks to siblings of an affected person depend on whether the affected person has a new mutation or inherited MHS from a parent. If a parent has MHS, each sibling as a 50% (1 in 2) risk to have MHS. When both parents appear unaffected based on evaluation, the risk to siblings of an affected person appears to be low.<br />\r\n<br />\r\nThe risk to other family members of an affected person also depend on whether an affected person's parent has the condition. If a parent also has MHS, other family members are at risk.[7497]<br />\r\n<br />\r\nPeople interested in learning about specific genetic risks to themselves or family members should speak with a genetics professional.","dateModified":"2014-06-30T10:12:00","resourceClassificationName":"Inheritance","references":[{"referenceId":7497,"authors":"Henry Rosenberg, Nyamkhishig Sambuughin, Sheila Riazi, and Robert Dirksen","articleTitle":"Malignant hyperthermia susceptibility","bookWebsiteJournalTitle":"GeneReviews","date":"January 31, 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1146/","dateAccessed":"2014-06-30T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":3363,"relatedDiseaseName":"Malignant hyperthermia susceptibility type 1","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":3364,"relatedDiseaseName":"Malignant hyperthermia susceptibility type 2","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":3365,"relatedDiseaseName":"Malignant hyperthermia susceptibility type 3","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":3366,"relatedDiseaseName":"Malignant hyperthermia susceptibility type 4","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":3367,"relatedDiseaseName":"Malignant hyperthermia susceptibility type 5","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":3368,"relatedDiseaseName":"Malignant hyperthermia susceptibility type 6","relation":"Child","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":46641,"abbreviatedInquiry":"Is the health of a person with malignant hyperthermia only jeopardized when anesthesia is used or are there daily complications that a person with this condition has to endure if they don't receive some sort of treatment?","caseQuestions":[{"questionId":7630,"questionText":"Can malignant hyperthermia cause health concerns in daily life or is the condition only triggered by anesthesia?&nbsp;","answerText":"The vast majority of malignant hyperthermia cases occur during or immediately following anesthesia. However, there is growing evidence that some patients may develop malignant hyperthermia with exercise and/or exposure to hot environments (after heat stroke).[7545]<br />\r\n<br />\r\n<a href=\"http://www.mhaus.org/healthcare-professionals/mhaus-recommendations/adverse-effects-of-heat-and-exercise-in-relation-to-mh-susceptibility\" target=\"_blank\">Click here</a> to access additional information related to this topic compiled by the Malignant Hyperthermia Association of America.&nbsp;","dateModified":"2014-07-22T15:38:00","references":[{"referenceId":7545,"authors":"","articleTitle":"What is MH?","bookWebsiteJournalTitle":"Malignant Hyperthermia Association of America","date":"2014","volume":"","pages":"","url":"http://www.mhaus.org/","dateAccessed":"2014-07-22T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}]},{"caseId":46395,"abbreviatedInquiry":"My brother has malignant hyperthermia. What are the chances his parents, siblings, children, nieces, and nephews will have it?","caseQuestions":[{"questionId":7587,"questionText":"Is malignant hyperthermia inherited?","answerText":"While malignant hyperthermia itself is not inherited, malignant hyperthermia susceptibility (MHS) is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner. This means that having a mutation in only one copy of the responsible gene is enough to make someone susceptible to having malignant hyperthermia.<br />\r\n<br />\r\nMost people diagnosed with malignant hyperthermia or MHS have a parent with MHS; however, the parent may not have experienced an episode of malignant hyperthermia. Therefore, the family history may appear to be negative when other family members are susceptible. In some cases, a person with MHS is affected due to having a new (de novo) mutation that was not inherited from a parent. Parents of a person with an apparently new mutation may be evaluated by having contracture testing (a muscle biopsy to determine susceptibility) or molecular genetic testing, if the mutation in the affected person is known.<br />\r\n<br />\r\nEach child of a person with MHS has a 50% (1 in 2) risk to inherit MHS.<br />\r\n<br />\r\nThe risks to siblings of an affected person depend on whether the affected person has a new mutation or inherited MHS from a parent. If a parent has MHS, each sibling as a 50% (1 in 2) risk to have MHS. When both parents appear unaffected based on evaluation, the risk to siblings of an affected person appears to be low.<br />\r\n<br />\r\nThe risk to other family members of an affected person also depend on whether an affected person's parent has the condition. If a parent also has MHS, other family members are at risk.[7497]<br />\r\n<br />\r\nPeople interested in learning about specific genetic risks to themselves or family members should speak with a genetics professional.","dateModified":"2014-06-30T10:12:00","resourceClassificationName":"Inheritance","references":[{"referenceId":7497,"authors":"Henry Rosenberg, Nyamkhishig Sambuughin, Sheila Riazi, and Robert Dirksen","articleTitle":"Malignant hyperthermia susceptibility","bookWebsiteJournalTitle":"GeneReviews","date":"January 31, 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1146/","dateAccessed":"2014-06-30T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2567,"questionText":"How can I find a genetics professional in my area?","answerText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by  the <a href=\"https://www.acmg.net/ACMG/Find_Genetic_Services/ACMG/ISGweb/FindaGeneticService.aspx?hkey=720856ab-a827-42fb-a788-b618b15079f9\" target=\"_blank\">American College of Medical Genetics</a>&nbsp;and the&nbsp;<a href=\"https://www.findageneticcounselor.com/\" target=\"_blank\">National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also <a href=\"http://ghr.nlm.nih.gov/handbook/consult?show=all\" target=\"_blank\">learn more about genetic consultations</a> from Genetics Home Reference.","dateModified":"2017-12-06T00:00:00","references":[]}]},{"caseId":32204,"abbreviatedInquiry":"Can&nbsp;malignant hyperthermia&nbsp;be transferred by blood donations? And at what age up to&nbsp;can you still donate blood?","caseQuestions":[{"questionId":5315,"questionText":"Can people with malignant hyperthermia donate blood? Can malignant hyperthermia be contracted from blood donations?","answerText":"According to the <a href=\"http://www.mhaus.org/\" target=\"_blank\">Malignant Hyperthermia Association of the United States</a>&nbsp;there is no contraindication to blood or organ donation by a&nbsp;person with malignant hyperthermia. Malignant hyperthermia is&nbsp;not \"carried\" in the blood or organs.&nbsp;","dateModified":"2011-09-19T15:49:00","references":[]},{"questionId":5316,"questionText":"Up to what age are individuals able to donate blood?","answerText":"According to the American Red Cross, to give blood you must be healthy, be at least 17 years old, weigh at least 110 pounds, and not have donated blood in the last 56 days. There is no upper age limit as long as you are well with no restrictions or limitations to your activities. Please visit the American Red Cross Web site at the following link to view further eligibility requirements for blood donation:<br><a href=\"http://www.redcrossblood.org/donating-blood/eligibility-requirements\" target=_blank>http://www.redcrossblood.org/donating-blood/eligibility-requirements</a>","dateModified":"2011-09-19T15:49:00","references":[]},{"questionId":5317,"questionText":"How can I find further information on malignant hyperthermia?","answerText":"If you have further questions on malignant hyperthermia you can contact the Malignant Hyperthermia Association of the United States using the contact information below:\r\n<p>Malignant Hyperthermia Association of the United States (MHAUS)<br>11 East State St<br>PO Box 1069<br>Sherburne, NY 13460<br>Toll-free (Information line): (800) 986-4287<br>Telephone: (607) 674-7901<br>E-mail: <a href=\"mailto:info@mhaus.org\">info@mhaus.org</a><br>Web site: <a href=\"http://www.mhaus.org/\" target=_blank>http://www.mhaus.org/</a></p>\r\n<p>You can also find a list of information resources&nbsp;on this topic on our Web site at the following link:<br><a href=\"http://rarediseases.info.nih.gov/GARD/Condition/6964/Malignant_hyperthermia.aspx/Showall#Resources\" target=_blank>http://rarediseases.info.nih.gov/GARD/Condition/6964/Malignant_hyperthermia.aspx/Showall#Resources</a></p>","dateModified":"2011-09-19T15:50:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":7149,"phenoTypeName":"Cardiomyocyte mitochondrial proliferation","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13043,"phenoTypeName":"Fever","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":2438,"phenoTypeName":"Hypercapnia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4312,"phenoTypeName":"Hyperphosphatemia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13235,"phenoTypeName":"Intermittent painful muscle spasms","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13439,"phenoTypeName":"Malignant hyperthermia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13040,"phenoTypeName":"Metabolic acidosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6236,"phenoTypeName":"Muscle stiffness","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9927,"phenoTypeName":"Supraventricular tachycardia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":7889,"phenoTypeName":"Tachypnea","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9930,"phenoTypeName":"Ventricular tachycardia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":758,"phenoTypeName":"Abnormality of masseter muscle","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10945,"phenoTypeName":"Abnormality of the coagulation cascade","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10199,"phenoTypeName":"Acute hepatic failure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15550,"phenoTypeName":"Acute kidney injury","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3503,"phenoTypeName":"Acute rhabdomyolysis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15630,"phenoTypeName":"Elevated creatine kinase after exercise","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3468,"phenoTypeName":"Exercise-induced rhabdomyolysis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3869,"phenoTypeName":"High-output congestive heart failure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13832,"phenoTypeName":"Hyperkalemia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4321,"phenoTypeName":"Myoglobinuria","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3441,"phenoTypeName":"Necrotizing myopathy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":50,"phenoTypeName":"Ventricular extrasystoles","frequencyText":"Occasional","percentRanges":"5%-29%"}],"medicalProducts":[{"productId":603,"genericName":"dantrolene sodium suspension for injection","tradeName":"Ryanodex","tradeLink":"http://eaglepharmaceutical.com/products/commercial-products/ryanodex-mh","manufacturer":"","sponsor":"Eagle Pharmaceuticals, Inc.","indication":"Treatment of malignant hyperthermia in conjunctin with appropriate supportive measures.","drugInformationLink":"http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=RYANODEX","medlinePlusLink":""}],"EncodedName":"Malignant_hyperthermia"}